Pfizer seeking emergency use of COVID-19 vaccine
Pfizer Inc. announced Friday that they seeking approval of U.S. regulators to allow the use of it’s COVID-19 vaccine.
Before any vaccine is approved for the public the U.S. Food and Drug Administration must conduct a full review of the vaccine trials, a process that normally takes about a decade.
The pandemic has caused the federal government to use various methods to speed up the process for COVID-19 vaccines.
On Wednesday, Pfizer released it’s preliminary data showing the vaccine is 95% effective.
The company said the data and good safety measures should help the vaccine qualify for emergency use authorization.
Watch the video for the full story.
Higher demand, lower supply leads to Christmas tree shortage
CON MI GENTE: The Tamalada Ladies
Valley Made, Local Strong: Williedean Bagels
City of Pharr urging small businesses to have social media presence during...
Hospitals prepare for surge as some Valley schools begin in-person learning